These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3548445)

  • 1. Expenditure effects of changes in Medicaid benefit coverage: an alcohol and substance abuse example.
    Reutzel TJ; Becker FW; Sanders BK
    Am J Public Health; 1987 Apr; 77(4):503-4. PubMed ID: 3548445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicaid support of alcohol, drug abuse, and mental health services.
    Wright GE; Buck JA
    Health Care Financ Rev; 1991; 13(1):117-28. PubMed ID: 10170864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of substance abuse treatment on Medicaid expenditures among general assistance welfare clients in Washington state.
    Wickizer TM; Krupski A; Stark KD; Mancuso D; Campbell K
    Milbank Q; 2006; 84(3):555-76. PubMed ID: 16953810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the costs of substance abuse to the Medicaid hospital care program.
    Fox K; Merrill JC; Chang HH; Califano JA
    Am J Public Health; 1995 Jan; 85(1):48-54. PubMed ID: 7832261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of health economics in substance abuse research. Recent advances and future opportunities. Overview.
    French MT
    Recent Dev Alcohol; 2001; 15():201-8. PubMed ID: 11449742
    [No Abstract]   [Full Text] [Related]  

  • 6. Public spending for illegal drug and alcohol treatment in hospitals: an EU cross-country comparison.
    Lievens D; Vander Laenen F; Christiaens J
    Subst Abuse Treat Prev Policy; 2014 Jun; 9():26. PubMed ID: 24981850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Employer-sponsored insurance coverage for alcohol and drug abuse treatment, 1988.
    Jensen GA; Morrisey MA
    Inquiry; 1991; 28(4):393-402. PubMed ID: 1761312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of alcohol and drug treatment programs.
    Caldwel JR
    J Fla Med Assoc; 1993 Jun; 80(6):385-6. PubMed ID: 8340771
    [No Abstract]   [Full Text] [Related]  

  • 9. Alcohol and other drug treatment commissioning and purchasing: Is it health care or social-welfare?
    Ritter A; van de Ven K
    Drug Alcohol Rev; 2019 Feb; 38(2):119-122. PubMed ID: 30350393
    [No Abstract]   [Full Text] [Related]  

  • 10. Organizational and financial issues in the delivery of substance abuse treatment services.
    Horgan CM; Reif S; Ritter GA; Lee MT
    Recent Dev Alcohol; 2001; 15():9-26. PubMed ID: 11449759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of an innovative Medicaid health policy initiative to expand substance abuse treatment in Washington State.
    Wickizer TM; Mancuso D; Huber A
    Med Care Res Rev; 2012 Oct; 69(5):540-59. PubMed ID: 22618867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effective treatment in Brazil and elsewhere.
    Heather N
    Addiction; 2001 Jul; 96(7):1069-70. PubMed ID: 11440617
    [No Abstract]   [Full Text] [Related]  

  • 13. Is conventional wisdom wrong? Coverage for substance abuse treatment under Medicaid managed care.
    Maglione M; Ridgely MS
    J Subst Abuse Treat; 2006 Jun; 30(4):285-90. PubMed ID: 16716842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicaid expenditures on behavioral health care.
    Mark TL; Buck JA; Dilonardo JD; Coffey RM; Chalk M
    Psychiatr Serv; 2003 Feb; 54(2):188-94. PubMed ID: 12556599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost Savings from a Navigator Intervention for Repeat Detoxification Clients.
    Hodgkin D; Brolin MF; Ritter GA; Torres ME; Merrick EL; Horgan CM; Hopwood JC; De Marco N; Gewirtz A
    J Ment Health Policy Econ; 2019 Mar; 22(1):3-13. PubMed ID: 30991351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicaid care management: description of high-cost addictions treatment clients.
    Neighbors CJ; Sun Y; Yerneni R; Tesiny E; Burke C; Bardsley L; McDonald R; Morgenstern J
    J Subst Abuse Treat; 2013 Sep; 45(3):280-6. PubMed ID: 23579079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs of alcohol and drug abuse in the United States, 1992. Alcohol/Drugs COI Study Team.
    Holland P; Mushinski M
    Stat Bull Metrop Insur Co; 1999; 80(4):2-9. PubMed ID: 10553265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample.
    Parthasarathy S; Weisner CM
    Drug Alcohol Depend; 2005 Nov; 80(2):231-40. PubMed ID: 15916868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicaid reimbursement of primary care providers for treatment of substance use disorders.
    Haack MR; Alemi FF
    Subst Abus; 2002 Sep; 23(3 Suppl):95-104. PubMed ID: 23580989
    [No Abstract]   [Full Text] [Related]  

  • 20. Pennsylvania's Medical Home Initiative: Reductions in Healthcare Utilization and Cost Among Medicaid Patients with Medicaland Psychiatric Comorbidities.
    Rhodes KV; Basseyn S; Gallop R; Noll E; Rothbard A; Crits-Christoph P
    J Gen Intern Med; 2016 Nov; 31(11):1373-1381. PubMed ID: 27353455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.